EGFR and glioblastoma: Notable pathways included MAPK signaling, cancer pathways, EGF/EGFR signaling, Glioblastoma signaling, Ras signaling, EGFR tyrosine kinase inhibitor resistance, miRs in cancer, PI3K-AKT signaling, p38 MAPK signaling, glioma, miRs in cardiomyocyte hypertrophy, and mTOR signaling (Fig 7A).